160 Health Sets 28 Aug 2026 Board Meeting to Review 1H26 Unaudited Results and Potential Interim Dividend

Bulletin Express

Aug 18

160 Health International Limited has scheduled a board meeting for 28 August 2026. Directors will review and approve the Group’s unaudited financial results for the six months ended 30 June 2026 and discuss the declaration of an interim dividend, if any.

The meeting will be chaired by Mr. Luo Ningzheng, who serves as Chairman, Executive Director and Chief Executive Officer. The current Board comprises four executive directors, one non-executive director and three independent non-executive directors, as disclosed in the announcement dated 18 August 2026.

No further financial figures or dividend details were provided in the announcement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1146496210"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1146496210\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1146496210?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-18 17:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1146496210","market":"us","top_or_hot":-1,"title":"160 Health Sets 28 Aug 2026 Board Meeting to Review 1H26 Unaudited Results and Potential Interim Dividend","media":"Bulletin Express","content":"<p>160 Health International Limited has scheduled a board meeting for 28 August 2026. Directors will review and approve the Group’s unaudited financial results for the six months ended 30 June 2026 and discuss the declaration of an interim dividend, if any.</p>\n<p>The meeting will be chaired by Mr. Luo Ningzheng, who serves as Chairman, Executive Director and Chief Executive Officer. The current Board comprises four executive directors, one non-executive director and three independent non-executive directors, as disclosed in the announcement dated 18 August 2026.</p>\n<p>No further financial figures or dividend details were provided in the announcement.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>160 Health Sets 28 Aug 2026 Board Meeting to Review 1H26 Unaudited Results and Potential Interim Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n160 Health Sets 28 Aug 2026 Board Meeting to Review 1H26 Unaudited Results and Potential Interim Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-18 17:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>160 Health International Limited has scheduled a board meeting for 28 August 2026. Directors will review and approve the Group’s unaudited financial results for the six months ended 30 June 2026 and discuss the declaration of an interim dividend, if any.</p>\n<p>The meeting will be chaired by Mr. Luo Ningzheng, who serves as Chairman, Executive Director and Chief Executive Officer. The current Board comprises four executive directors, one non-executive director and three independent non-executive directors, as disclosed in the announcement dated 18 August 2026.</p>\n<p>No further financial figures or dividend details were provided in the announcement.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02656","symbol_name":"健康160","start_time":0,"source_url":"","article_id":"1146496210","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1146496210","pubTimestamp":1787043950,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"160 Health International Limited has scheduled a board meeting for 28 August 2026. Directors will review and approve the Group’s unaudited financial results for the six months ended 30 June 2026 and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02656":"健康160"},"translate_title":"160 Health 将于 2026 年 8 月 28 日召开董事会会议，审查 26 年上半年未经审计业绩和潜在中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02656":1},"content_text":"160 Health International Limited has scheduled a board meeting for 28 August 2026. Directors will review and approve the Group’s unaudited financial results for the six months ended 30 June 2026 and discuss the declaration of an interim dividend, if any.\nThe meeting will be chaired by Mr. Luo Ningzheng, who serves as Chairman, Executive Director and Chief Executive Officer. The current Board comprises four executive directors, one non-executive director and three independent non-executive directors, as disclosed in the announcement dated 18 August 2026.\nNo further financial figures or dividend details were provided in the announcement.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}